Review of: Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signalling pathways but not modulation of progesterone receptor activity
(Accepted November 12 2004) (BCO Pub date January 28 2005) Correspondence: c1 Correspondence to: Adrian V. Lee, The Breast Center, Baylor College of Medicine and the Methodist Hospital, Houston, TX, USA. E-mail: avlee@breastcenter.tmc.edu; Tel +1 713 798 1624; Fax: +1 713 798 1642 |